Navigation Links
ChemoCentryx Reports Novel CCR2 Antagonist Significantly Improves Kidney Function and Hyperglycemia in Models of Type 2 Diabetes
Date:6/27/2011

MOUNTAIN VIEW, Calif., June 27, 2011 /PRNewswire/ -- ChemoCentryx, Inc. today announced that the Company's novel CCR2 antagonist significantly improves kidney function and hyperglycemia in experimental models.  These data implicate CCR2-driven processes in the pathology of type 2 diabetes and associated complications such as diabetic nephropathy.  Results were highlighted in a poster presentation entitled "CCR2 Antagonism Improves Renal Function and Hyperglycemia in Preclinical Models of Type 2 Diabetes" at the 71st Scientific Session of the American Diabetes Association held in San Diego.  CCX140, the Company's lead novel, orally available CCR2 antagonist, successfully met its primary endpoint of safety and tolerability in a Phase II clinical trial in type 2 diabetes, while demonstrating clinical activity on glycemic indices following only 28 days of treatment.  CCX140 is currently poised to enter Phase II clinical development for the treatment of diabetic nephropathy.

"In the United States there are more than 31 million patients living with chronic kidney disease, 37% as a result of having diabetes," stated Thomas J. Schall, Ph.D., President and Chief Executive Officer of ChemoCentryx.  "Complicating matters further is the fact that the current standard of care does not stop or reverse progression and with the increasing number of patients who progress to end-stage renal disease each year -- there is a clear demand for better treatment options.  We believe these data demonstrate compelling rationale to move forward CCX140, our most advanced CCR2 antagonist, in a Phase II clinical trial for the treatment of diabetic nephropathy."

CCR2 inhibition was studied in two models of type 2 diabetes:  diet-induced obese mice and db/db mice. Treatment with the CCR2 antagonist significantly improved multiple metabolic/renal parameters in obese, diabetic mice, including hyperglycemia, insulin sensitivity, serum adiponec
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ChemoCentryx Initiates Phase I Clinical Trial of CCX832, the First Small Molecule Inhibitor of ChemR23
2. ChemoCentryx to Present at the 29th Annual J.P. Morgan Healthcare Conference
3. ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR)
4. ChemoCentryx Reports One-Year Results from PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Treating Patients with Crohns Disease at the United European Gastroenterology Federation (UEGW) Meeting
5. ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD)
6. ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohns Disease at the Digestive Disease Week (DDW) 2010 Conference
7. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
8. ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis
9. ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Maintaining Remission in Patients with Crohns Disease
10. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
11. PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryxs Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... Oct. 24, 2014 Research and Markets ... Market Current Trends, Opportunities - Global Forecast to 2019" ... this report, the global dental equipment market is categorized ... systems and equipment market is expected to register the ... the forecast period (2014 to 2019). This high growth ...
(Date:10/25/2014)... Oct. 24, 2014  America,s future engineers will ... competition at the  Medical Design and Manufacturing (MD&M) ... th at the Minneapolis ... student built robots from the "For Inspiration and ... students and mentors will offer information to those ...
(Date:10/25/2014)... Research and Markets ( ... "Global and Chinese Hemodialysis Concentrates Industry Report ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , Global and ... professional and in-depth study on the current state ... on the Chinese situation. The report ...
Breaking Medicine Technology:Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center 2Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center 3Global and Chinese Hemodialysis Concentrates Industry Report 2014 2Global and Chinese Hemodialysis Concentrates Industry Report 2014 3
... 29, 2011 Leading event organiser UBM has ... portfolio of annual pharmaceutical events including CPhI Worldwide ... services, P-MEC Europe for equipment, machinery and technology ... Hosted at Messe Frankfurt, Germany from the 25th ...
...  Henry Schein, Inc. (Nasdaq: HSIC ), ... services to office-based practitioners, today announced the launch ... an integrated wellness and education program that informs ... and total health, and assists dental professionals in ...
Cached Medicine Technology:Record Year for UBM's Pharma Events in Frankfurt 2Record Year for UBM's Pharma Events in Frankfurt 3Record Year for UBM's Pharma Events in Frankfurt 4Henry Schein Dental Launches Total Health™ Beyond the Mouth 2Henry Schein Dental Launches Total Health™ Beyond the Mouth 3
(Date:10/25/2014)... (PRWEB) October 25, 2014 Homeowners that ... has ‘gone bad’ need wonder no more. Clean Crawls ... homeowners should watch out for when it comes to ... according to the article released by Clean Crawls, can ... homeowners that any insulation that has deteriorated, become damp, ...
(Date:10/25/2014)... (PRWEB) October 25, 2014 Limbkeepers® announced ... episode of Innovations with Ed Begley Jr, airing 1st ... TBA. , In this episode, Innovations will focus on ... to protect fragile, thinning skin on arms, hands, and ... learn about these versatile products, which help reduce injuries, ...
(Date:10/25/2014)... Not getting the right amount of sleep might raise ... Those who sleep less or more than the ... more prone to developing the chronic condition, which causes ... concluded that duration and quality of sleep are key ... diseases. "Both short and long durations of sleep ...
(Date:10/25/2014)... 2014 (HealthDay News) -- Current osteoporosis screening guidelines ... women at risk for osteoporosis-related fractures, a new ... fractures, we need tools that help us accurately ... that we can target these at-risk people for ... of medicine in the division of general internal ...
(Date:10/22/2014)... At a time when the national concussion conversation ... all levels, the UPMC Sports Medicine Concussion Program ... two powerful messages are lost: Concussions can be treated, ... recoveries every day. , In striving to shift the ... UPMC and the Concussion Program are unveiling the online ...
Breaking Medicine News(10 mins):Health News:5 Signs Indicating That Insulation Needs Replacing as Told By Clean Crawls in Recent Article 2Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2Health News:University of Pittsburgh Medical Center Launches Initiative to Emphasize Concussions Are Treatable 2Health News:University of Pittsburgh Medical Center Launches Initiative to Emphasize Concussions Are Treatable 3Health News:University of Pittsburgh Medical Center Launches Initiative to Emphasize Concussions Are Treatable 4
... Hillenbrand, Inc.,(NYSE: HI ) will announce its fourth-quarter ... The full text of the release and,financials will be ... The company will hold a conference call and ... 8 a.m. ET. The webcast is,available through the Investor ...
... Initial Physician Experience with Eculizumab in Patients ... Presented, CHESHIRE, Conn., Nov. 10 ... announced that the American,Society of Hematology (ASH) ... as a treatment for patients with paroxysmal,nocturnal ...
... CINCINNATI Researchers have generated the first comprehensive ... light on the genetic and molecular dynamics of ... sponsored by the National Institute of Diabetes and ... led by Cincinnati Children,s Hospital Medical Center reports ...
... family caregivers of Alzheimer,s disease patients succumb to the ... become hospital patients themselves, according to an Indiana University ... Journal of General Internal Medicine . , ... Regenstrief Institute and the Indiana University Center for Aging ...
... French . , Dr. Ronald Melzack ... and treatment of pain from the 1960s onward, has ... He and his four fellow 2009 inductees from across ... "brought distinction to Canada through their outstanding contributions to ...
... 10 The role of the nurse,practitioner (NP) ... across the,country celebrate more than four decades of ... distinguished group of healthcare,providers number approximately 125,000 strong ... Events held in communities around the country ...
Cached Medicine News:Health News:Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting 2Health News:Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting 3Health News:Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting 4Health News:Genetic blueprint revealed for kidney design and formation 2Health News:Genetic blueprint revealed for kidney design and formation 3Health News:Caring for the caregiver: Redefining the definition of patient 2Health News:Trailblazing pain pioneer Ronald Melzack to be inducted into Medical Hall of Fame 2Health News:Celebrate 'Your Partner in Health - The Nurse Practitioner' 2
FLEXILOG spare part....
Complete calibration kits are available for both pH and manometry systems....
Flexilog custom medical carts are configured to suite the requirements of FLEXILOG motility system users. With locking wheels and storage drawers, our carts are suitable for any care provider in any ...
... kit for convenient pH catheter calibration., ,pH ... any procedure. The Alpine Calibration kit contains ... water for your convenience. Simply cut the ... catheters to soak. No measuring or pouring! ...
Medicine Products: